Andy Slavitt returns to discuss the health care proposals of the Democratic candidates for POTUS. Al and Andy agree that it’s important for every contender to lay out their plans to get to universal coverage, but exhort them not to squander the enormous advantage we have over Trump and Republicans on an issue of such importance to every American.
Andy Slavitt, the former head of Medicare, Medicaid, and the Affordable Care Act (ACA) under President Obama, joins us for a very special interview segment on the importance of the ACA for people with hemophilia. UK-based community advocate Laurence Woollard provides insight into the UK bleeding disorders community and his personal journey in hemophilia advocacy. Natalie leads a New York Times story on the debate surrounding how to price gene therapy treatments, and Patrick provides an overview of the recent, terrible news of a patient death during the Fitusrian clinical trial - what happened, what it means, and what happens next? Listen now on Episode 16 of The BloodStream Podcast. Exclusive Sponsor for Episode 16: Shire Like Share Comment Segments Like: NYT: New Gene-Therapy Treatments Will Carry Whopping Price Tags Share: Laurence Woollard’s “The Endeavour to Progress” Comment: Alnylam Suspends All Trials of Fitusiran After Hemophilia A Patient Dies in Phase 2 Study // Story from RareDr.com // Story from FierceBiotech Andy Slavitt Interview JAMA Forum: Reforming Medicaid USA Today Column: Spare America a do-over on health care. Seize the bipartisan moment. Other Links of Interest Clinical Trials 101 from HemAware Clinical Trials from the Hemophilia Federation of America Powering Through Podcast Ask The Expert Podcast Making-Of Bombardier Blood Video Stop The Bleeding! Season 7 - Behind The Story Videos Hope For Hemophilia BloodFeed: https://www.bloodfeed.com Powering Through Podcast http://poweringthrough.org/podcast Ask The Expert Podcast http://bloodstreamexpert.com